The UK’s 16- to 17-year-olds can expect to be offered a second dose of the Pfizer-BioNTech COVID-19 vaccine soon, with the government’s independent vaccines advisory committee making the recommendation on Monday. The Joint Committee on Vaccination and Immunisation (JCVI) also recommended mRNA booster doses for all adults aged 40 to 49 years in a televised briefing. The Pfizer-BioNTech vaccine is currently the only CCP (Chinese Communist Party) virus vaccine that is authorised for use on children over 12 years old. The JCVI advised giving one dose of the vaccine to 16- to 17-year-olds on Aug. 4. The committee on Monday said the older adolescent group should receive a second dose at least 12 weeks after their first shots, or at least 12 weeks after positive tests if they are later than the first shot. The JCVI suggested in a statement that the longer interval between the two shots in Canada and the UK correlates …